HK1076101A1 - Process for the preparation of high purity perindopril and intermediates useful in the synthesis - Google Patents

Process for the preparation of high purity perindopril and intermediates useful in the synthesis

Info

Publication number
HK1076101A1
HK1076101A1 HK05108134A HK05108134A HK1076101A1 HK 1076101 A1 HK1076101 A1 HK 1076101A1 HK 05108134 A HK05108134 A HK 05108134A HK 05108134 A HK05108134 A HK 05108134A HK 1076101 A1 HK1076101 A1 HK 1076101A1
Authority
HK
Hong Kong
Prior art keywords
synthesis
preparation
high purity
intermediates useful
purity perindopril
Prior art date
Application number
HK05108134A
Other languages
English (en)
Inventor
Gyula Simig
Tibor Mezei
Marta Porcs-Makkay
Attila Mandi
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of HK1076101A1 publication Critical patent/HK1076101A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK05108134A 2002-01-30 2005-09-16 Process for the preparation of high purity perindopril and intermediates useful in the synthesis HK1076101A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02290206A EP1333026B1 (en) 2002-01-30 2002-01-30 Process for the preparation of high purity perindopril and intermediates useful in the synthesis
PCT/IB2003/000691 WO2003064388A2 (en) 2002-01-30 2003-01-29 Process for the preparation of high purity perindopril and intermediates useful in the synthesis

Publications (1)

Publication Number Publication Date
HK1076101A1 true HK1076101A1 (en) 2006-01-06

Family

ID=8185713

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05108134A HK1076101A1 (en) 2002-01-30 2005-09-16 Process for the preparation of high purity perindopril and intermediates useful in the synthesis

Country Status (36)

Country Link
US (2) US7326794B2 (no)
EP (1) EP1333026B1 (no)
JP (1) JP4171423B2 (no)
KR (1) KR100673701B1 (no)
CN (1) CN1300111C (no)
AP (1) AP1741A (no)
AR (1) AR038340A1 (no)
AT (1) ATE365714T1 (no)
AU (1) AU2003206055B2 (no)
BG (1) BG66126B1 (no)
BR (2) BRPI0307293B1 (no)
CA (1) CA2474003C (no)
CY (1) CY1106721T1 (no)
CZ (1) CZ305892B6 (no)
DE (1) DE60220877T2 (no)
DK (1) DK1333026T3 (no)
EA (1) EA009277B1 (no)
EE (1) EE05428B1 (no)
ES (1) ES2289060T3 (no)
GE (1) GEP20063899B (no)
HK (1) HK1076101A1 (no)
HR (1) HRP20040781B8 (no)
HU (1) HU227591B1 (no)
ME (1) ME00444B (no)
MX (1) MXPA04007444A (no)
NO (1) NO330223B1 (no)
NZ (1) NZ534168A (no)
OA (1) OA12759A (no)
PL (1) PL212354B1 (no)
PT (1) PT1333026E (no)
RS (1) RS52465B (no)
SI (1) SI1333026T1 (no)
SK (1) SK287866B6 (no)
UA (1) UA77756C2 (no)
WO (1) WO2003064388A2 (no)
ZA (1) ZA200405548B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60330603D1 (de) * 2003-10-21 2010-01-28 Servier Lab Verfahren zur herstellung kristallinem perindopril erbumin
SI21704A (en) * 2004-01-14 2005-08-31 Lek Farmacevtska Druzba Dd New crystal form of perindopril, procedure of its preparation, pharmaceutical preparations containing this form and their application in treatment of hypertensia
WO2005094793A1 (en) * 2004-03-29 2005-10-13 Krka, Tovarna Zdravil, D.D., Novo Mesto Process for preparing a solid pharmaceutical composition
SI21800A (sl) * 2004-05-14 2005-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nov postopek sinteze perindoprila
SI21881A (sl) 2004-10-15 2006-04-30 Diagen, Smartno Pri Ljubljani, D.O.O. Nove kristalne oblike perindopril erbumin hidratov, postopek za njihovo pripravo in farmacevtske oblike, ki vsebujejo te spojine
ES2255872B1 (es) * 2004-12-31 2007-08-16 Quimica Sintetica, S.A. Procedimiento para la preparacion de perindopril erbumina.
ES2314583T4 (es) 2005-01-06 2009-05-18 Ipca Laboratories Limited Proceso para sintesis de los derivados del acido (2s,3as,7as)-1-(s)-alanil-octahidro-1h-indol-2-carboxilico y su utilizacion en la sintesis de perindropil.
US7710739B2 (en) 2005-04-28 2010-05-04 Semiconductor Energy Laboratory Co., Ltd. Semiconductor device and display device
WO2006137082A1 (en) * 2005-06-23 2006-12-28 Ramesh Babu Potluri Process for industrially viable preparation of perindopril erbumine
US20070032661A1 (en) * 2005-08-03 2007-02-08 Glenmark Pharmaceuticals Limited Process for the preparation of intermediates of perindopril
UA92613C2 (ru) * 2005-08-12 2010-11-25 Лек Фармасьютиклз Д.Д. Способ получения кристаллической формы d эрбумина периндоприла
EP1792896A1 (en) * 2005-12-01 2007-06-06 KRKA, tovarna zdravil, d.d., Novo mesto Process for the preparation of perindopril and salts thereof
UA98767C2 (uk) * 2006-05-12 2012-06-25 Егіш Дьйодьсердьяр Нільваношан Мюкьодо Ресвеньтаршашаг Фармацевтичні проміжні сполуки в синтезі інгібіторів ацетилхолінестерази (асе)
WO2016178591A2 (en) 2015-05-05 2016-11-10 Gene Predit, Sa Genetic markers and treatment of male obesity
FR3050380B1 (fr) 2016-04-20 2020-07-10 Les Laboratoires Servier Composition pharmaceutique comprenant un betabloquant, un inhibiteur de l'enzyme de conversion et un antihypertenseur ou un ains.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK144769C (da) 1979-12-06 1982-12-13 Voelund Vaskerimaskiner Tromlevaskemaskine med varmeveksler
FR2503155A2 (fr) * 1980-10-02 1982-10-08 Science Union & Cie Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
US4565819A (en) * 1979-12-07 1986-01-21 Adir Substituted imino diacids, their preparation and pharmaceutical compositions which contain them
IN156096B (no) 1981-03-19 1985-05-11 Usv Pharma Corp
FR2620709B1 (fr) * 1987-09-17 1990-09-07 Adir Procede de synthese industrielle du perindopril et de ses principaux intermediaires de synthese
SI9600169A (en) 1996-05-22 1997-12-31 Krka Tovarna Zdravil Process for preparation of compounds with ace inhibitory effect
FR2807431B1 (fr) 2000-04-06 2002-07-19 Adir Nouveau procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables
AR036187A1 (es) 2001-07-24 2004-08-18 Adir Un proceso para la preparacion de perindopril, compuestos analogos y sus sales, compuesto intermediario 2,5-dioxo-oxazolidina y proceso para preparar un intermediario
FR2827860B1 (fr) 2001-07-24 2004-12-10 Servier Lab Nouveau procede de synthese de derives de l'acide (2s, 3as, 7as)-1-[(s)-alanyl]-octahydro-1h-indole-2-carboxyline et application a la synthese du perindopril

Also Published As

Publication number Publication date
HRP20040781A8 (en) 2009-01-31
NZ534168A (en) 2006-11-30
HRP20040781A2 (en) 2004-12-31
US20050119492A1 (en) 2005-06-02
US7326794B2 (en) 2008-02-05
HRP20040781B8 (en) 2009-01-31
PL212354B1 (pl) 2012-09-28
GEP20063899B (en) 2006-08-10
SK3292004A3 (en) 2004-12-01
CZ305892B6 (cs) 2016-04-27
EA200400929A1 (ru) 2005-06-30
NO20043472L (no) 2004-08-20
EE200400107A (et) 2004-10-15
BG108858A (en) 2005-05-31
US20070197821A1 (en) 2007-08-23
AR038340A1 (es) 2005-01-12
AP2004003091A0 (en) 2004-09-30
DE60220877T2 (de) 2008-04-10
BRPI0307293B1 (pt) 2018-03-06
DE60220877D1 (de) 2007-08-09
KR20040078680A (ko) 2004-09-10
HU227591B1 (hu) 2011-09-28
ATE365714T1 (de) 2007-07-15
CA2474003C (en) 2009-06-02
SI1333026T1 (sl) 2007-10-31
CZ2004906A3 (cs) 2004-12-15
WO2003064388A2 (en) 2003-08-07
OA12759A (en) 2006-07-04
AP1741A (en) 2007-05-16
CN1300111C (zh) 2007-02-14
US7279595B2 (en) 2007-10-09
HU0300231D0 (en) 2003-03-28
EE05428B1 (et) 2011-06-15
HRP20040781B1 (en) 2008-12-31
KR100673701B1 (ko) 2007-01-24
EP1333026A1 (en) 2003-08-06
JP4171423B2 (ja) 2008-10-22
UA77756C2 (uk) 2007-01-15
EA009277B1 (ru) 2007-12-28
AU2003206055B2 (en) 2008-07-17
PT1333026E (pt) 2007-09-17
ZA200405548B (en) 2006-09-27
EP1333026B1 (en) 2007-06-27
JP2005521667A (ja) 2005-07-21
NO330223B1 (no) 2011-03-07
CN1622936A (zh) 2005-06-01
RS66704A (en) 2007-02-05
ME00444B (me) 2011-10-10
SK287866B6 (sk) 2012-02-03
ES2289060T3 (es) 2008-02-01
RS52465B (en) 2013-02-28
HUP0300231A2 (hu) 2003-08-28
HUP0300231A3 (en) 2004-04-28
WO2003064388A3 (en) 2004-02-05
BR0307293A (pt) 2004-12-21
CA2474003A1 (en) 2003-08-07
CY1106721T1 (el) 2012-05-23
BG66126B1 (bg) 2011-06-30
MXPA04007444A (es) 2005-06-17
PL358514A1 (en) 2003-07-28
DK1333026T3 (da) 2007-10-22

Similar Documents

Publication Publication Date Title
HK1076101A1 (en) Process for the preparation of high purity perindopril and intermediates useful in the synthesis
SI1644384T1 (sl) Postopek in intermediati za sintezo entekavirja
AU2003274439A1 (en) Production of synthesis gas and synthesis gas derived products
IL180290A0 (en) Process for production of azulene derivatives and intermediates for the synthesis of the same
IL214165A0 (en) Intermediates useful in the synthesis of statin derivatives
HK1089187A1 (en) Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
EG24152A (en) Novel method for the synthesis of s-indoline-2-carboxylic acid and application thereof in synthesis of perindopril
AU2002368505A1 (en) Novel intermediates for synthesis of cephalosporins and process for preparation of such intermediates
IL223579A0 (en) Synthesis of amines and intermediates for the synthesis thereof
HK1096409A1 (en) Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
HK1096408A1 (en) Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
ZA200601426B (en) Novel method for the synthesis of perindopril and the pharmaceutically-acceptable salts thereof
HK1096407A1 (en) Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
HK1096406A1 (en) Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
AU2003300018A8 (en) Process for the preparation of tri-nitrogen containing heteroaryl-diamine derivatives useful as pharmaceutical agents and methods of producing pharmaceutical agents
SI1403275T1 (sl) Nov postopek sinteze perindoprila in njegovih farmacevtsko sprejemljivih soli
AU2003262928A8 (en) Crystalline form of nateglinide and process for preparation thereof
AU2003224327A8 (en) Process for the synthesis of peptides
AU2003225642A1 (en) Mappicine analogs, intermediates in the synthesis of mappicine analogs and methods of synthesis of mappicine analogs
AU1695901A (en) Process for the preparation of intermediates useful in the synthesis of diarylpyridines
HUP0203547A3 (en) Ondasetron hydrochlorid dihydrate of high purity and process for its producing

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190129